Applied Health Economics and Health Policy

Design of Patient Access Schemes in the UK: Influence of Health Technology Assessment by the National Institute for Health and Clinical Excellence
pp. 209-215(7)
Authors: Jarosławski, Szymon; Toumi, Mondher

Cost-Efficacy Analysis of the MONET Trial Using UK Antiretroviral Drug Prices
pp. 217-223(7)
Authors: Gazzard, Brian; Hill, Andrew; Anceau, Anne

Ordering Errors, Objections and Invariance in Utility Survey Responses: A Framework for Understanding Who, Why and What to Do
pp. 225-241(17)
Authors: Wittenberg, Eve; Prosser, Lisa A.

The Use of Decision-Analytic Models in Parkinson's Disease: A Systematic Review and Critical Appraisal
pp. 243-258(16)
Authors: Shearer, James; Green, Colin; Counsell, Carl E.; Zajicek, John P.

Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis
pp. 259-273(15)
Authors: Mueller, Dirk; Gandjour, Afschin

Drugs for Rare Diseases: Influence of Orphan Designation Status on Price
pp. 275-279(5)
Authors: Picavet, Eline; Dooms, Marc; Cassiman, David; Simoens, Steven